Moving Center Stage: patients claim their role in healthcare

Anke-Peggy Holtorf, Neil Bertelsen






Patient centricity; Patient and Public Involvement; Research and Development; Health Technology Assessment

Full Text



  • Balz V, Klöppel U, Hulverscheidt M, et al. Arzneimittel des 20. Jahrhunderts: Historische Skizzen von Lebertran bis Contergan (Science Studies) (Paperback)(German) - Common. Transcript Verlag, 2009
  • Crimp D. Before Occupy: How AIDS Activists Seized Control of the FDA in 1988. The Atlantic 2011. Available at: (Last accessed March 2016)
  • Rosenberg W, Donald A. Evidence based medicine: an approach to clinical problem-solving. BMJ 1995; 310: 1122-6;
  • Henshall C, Koch P, von Below GC, et al. Health Technology Assessment in Policy and Practice. Int J Technol Assess Health Care 2002; 18: 447-55;
  • Cuche M, Beckerman R, Chowdhury CA, et al. Early dialogue with health technology assessment bodies: a European perspective. Int J Technol Assess Health Care 2014; 30: 571-8;
  • EMA. European Medicines Agency – Patients and consumers. Available at: (Last accessed March 2016)
  • Hoos A, Anderson J, Boutin M, et al. Partnering With Patients in the Development and Lifecycle of Medicines: A Call for Action. Ther Innov Regul Sci 2015; 49: 929-39;
  • EULAR Secretariat, Switzerland. EULAR Standing Committee of PARE. Available at: (Last accessed March 2016)
  • Pushparajah D, Geissler J, Westergaard N. EUPATI: Collaborating between patients, academia and industry to champion the informed patient in medicines research and development. J Med Dev Sci 2015; 1 Available at (Last accessed March 2016)
  • Forst T, Hohberg C, Schöndorf T, et al. Time-action profile and patient assessment of inhaled insulin via the Exubera device in comparison with subcutaneously injected insulin aspart via the FlexPen device. Diabetes Technol Ther 2009; 11: 87-92;
  • Holtorf AP, Palacios D, Brixner DI. The Role of Patients in Clinical Research and Evidence Based Decision Making as Reported Via a Survey of Patient Advocates. Value in Health 2014; 17: A435;
  • Buck D, Gamble C, Dudley L, et al. From plans to actions in patient and public involvement: qualitative study of documented plans and the accounts of researchers and patients sampled from a cohort of clinical trials. BMJ Open 2014; 4: e006400;
  • Gamble C, Dudley L, Allam A, et al. An evidence base to optimise methods for involving patient and public contributors in clinical trials: a mixed-methods study. Southampton (UK): NIHR Journals Library, 2015
  • Dudley L, Gamble C, Preston J, et al. What Difference Does Patient and Public Involvement Make and What Are Its Pathways to Impact? Qualitative Study of Patients and Researchers from a Cohort of Randomised Clinical Trials. PLoS ONE 2015; 10: e0128817;
  • Carvel D. Patient-partners may be political correctness gone too far. BMJ 1999; 319: 783-4
  • AFM-Téléthon. Available at: (Last accessed March 2016)
  • Dunkle M, Pines W, Saltonstall PL. Advocacy groups and their role in rare diseases research. Adv Exp Med Biol 2010; 686: 515-25;
  • Staniszewska S, Crowe S, Badenoch D, et al. The PRIME project: developing a patient evidence-base. Health Expect 2010; 13: 312-22;


Abstract: 2473 views
HTML: 1126 views
PDF: 339 views


  • There are currently no refbacks.